(EPZM) - Earnings & Price History

EPZM: - 16.225, $967.61M, -0.48 (-2.84%)

Sector: Healthcare - Industry: Biotechnology

Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. The companys proprietary product platform creates small molecule inhibitors of enzymes known as histone methyltransferases (HMTs). Its lead product candidate includes tazemetostat, an inhibitor of the EZH2 HMT, which is in Phase II clinical study in adults with relapsed or refractory non-Hodgkin lymphoma; and in phase II study in adults and phase I study in children with certain genetically-defined solid tumors, as well as for the treatment of mesothelioma. The company is also developing additional programs, including a Phase I clinical trial of pinometostat, an inhibitor of the DOT1L HMT for the treatment of children with MLL-r, an acute leukemia with genetic alterations of the MLL gene. It has therapeutic collaboration agreements with Celgene Corporation, Celgene

Past EPZM reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-03-09BMO-0.6515.215.115.114.615.830.66%0.66%736.37K
2016-11-03BMO-0.68.89.18.98.59.45-2.20%▲-1.12%-3.30%496.94K
2016-08-08BMO-0.529.0510.32108.8110.09-3.10%-9.50%-12.31%1.05M
2016-05-09BMO-0.5310.169.339.048.8410.3-3.11%12.39%8.90%373.88K
2016-04-29BMO-0.5310.4211.061110.3211.35-0.54%-5.27%-5.79%305.81K
2016-04-28BMO-0.5311.0611.1611.0510.8211.58-0.99%0.09%-0.90%212.68K
2016-04-27BMO-0.5311.1611.031110.311.33-0.27%1.45%1.18%390.87K
2016-04-26BMO-0.5311.0312.1212.2310.9712.240.91%-9.81%-8.99%314.51K
2016-03-09BMO-0.659.539.399.548.59.761.60%-0.10%1.49%658.73K
2015-11-09BMO-0.5916.9916.8716.516.1417.13-2.19%▲2.97%0.71%478.28K
2015-08-06BMO-0.722.16522.2921.2421.0322.3-4.71%4.35%-0.56%21.14K
2015-04-28BMO-0.9919.2119.0719.2518.6419.780.94%-0.21%0.73%293.69K
2015-03-12BMO-0.5325.4522.1822.317.5925.480.54%14.13%14.74%1.51M
2015-02-27BMO-0.5323.5223.623.4922.9323.775-0.47%0.13%-0.34%152.91K
2015-02-26BMO-0.5323.624.0123.982323.98-0.12%-1.58%-1.71%184.49K
2015-02-25BMO-0.5324.0123.2723.172324.3-0.43%3.63%3.18%180.11K
2015-02-24BMO-0.5323.2723.3723.3722.91423.96-0.43%-0.43%250.58K
2015-02-23BMO-0.5323.3722.7622.7722.5923.820.04%2.64%2.68%246.12K
2014-11-06BMOEpizyme Inc-0.54-0.5823.5626.62419.6724-9.77%▲-1.83%-11.43%2.68M
2014-08-13BMOEpizyme Inc-0.46-0.434.6135.023533.0835.99-0.06%-1.11%-1.17%794.00K
2014-05-13AMCEpizyme Inc-0.48-0.2222.0122.2922.321.1122.590.04%-1.30%-1.26%270.40K
2014-02-27AMCEpizyme Inc-0.370.5229.931.8232.0128.81330.60%-6.59%-6.03%578.40K
2013-10-22AMCEpizyme Inc-0.36-0.3438.3139.623937.439.97-1.56%▲-1.77%-3.31%202.70K
2013-07-31AMCEpizyme Inc-0.26-0.2535.936.136.1535.17380.14%-0.69%-0.55%171.00K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades